Holen Sie sich die Stockscreener-App
1.96
2.97%
-0.06
Finanzdaten der Alaunos Therapeutics Inc-Aktie (TCRT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.00%
0.001
|
0.001 | - | 0.004 | - |
Operating Expenses
|
78.08%
1.743
|
7.95 | 8.664 | 7.986 | 9.672 |
| Interest Income/Expense |
-
|
- | - | 1.068 | 0.853 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
78.08%
1.743
|
7.95 | 8.665 | 7.986 | 9.671 |
| Operating Income/Loss |
78.09%
-1.742
|
-7.949 | -8.664 | -7.982 | -9.672 |
| Nonoperating Income/Loss |
43.40%
0.06
|
0.106 | 0.188 | -0.791 | -0.376 |
| Income/Loss From Continuing Operations Before Tax |
0.00%
0.001
|
0.001 | -8.476 | 0.004 | -10.05 |
| Income/Loss From Continuing Operations After Tax |
78.55%
-1.682
|
-7.843 | -8.476 | -8.773 | -10.05 |
|
Net Income/Loss
|
78.55%
-1.682
|
-7.843 | -8.476 | -8.773 | -10.05 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
107.15%
16.01
|
-223.85 | 240.05 | 239.80 | 239.68 |
| Diluted Average Shares |
107.15%
16.01
|
-223.85 | 240.05 | 239.80 | 239.68 |
| Basic Earnings Per Share |
94.74%
-0.11
|
-2.09 | -0.04 | -0.04 | -0.04 |
| Diluted Earnings Per Share |
94.74%
-0.11
|
-2.09 | -0.04 | -0.04 | -0.04 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):